Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double‐Blind, Randomized, Placebo‐Controlled Trial

BACKGROUND: The glucagon‐like peptide‐1 (GLP‐1) receptor agonist liraglutide may be beneficial in the regression of diabetic cardiomyopathy. South Asian ethnic groups in particular are at risk of developing type 2 diabetes. PURPOSE: To assess the effects of liraglutide on left ventricular (LV) diast...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Magn Reson Imaging
Hlavní autoři: Paiman, Elisabeth H.M., van Eyk, Huub J., van Aalst, Minke M.A., Bizino, Maurice B., van der Geest, Rob J., Westenberg, Jos J.M., Geelhoed‐Duijvestijn, Petronella H., Kharagjitsingh, Aan V., Rensen, Patrick C.N., Smit, Johannes W.A., Jazet, Ingrid M., Lamb, Hildo J.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318583/
https://ncbi.nlm.nih.gov/pubmed/31799782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmri.27009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky